Safety and Efficacy Evaluation of TPN in Preterm Neonates in NICU of Cairo University Children Hospital
1 other identifier
observational
200
1 country
1
Brief Summary
The aim of this work is evaluation of electrolytes and minerals homeostasis and occurrence of complications among preterm babies receiving total parenteral nutrition, and admitted to the neonatal intensive care units of Cairo University Children hospitals.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2019
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 7, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 7, 2020
CompletedFirst Submitted
Initial submission to the registry
January 21, 2021
CompletedFirst Posted
Study publicly available on registry
January 26, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 7, 2021
CompletedJanuary 26, 2021
January 1, 2021
11 months
January 21, 2021
January 21, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
electrolyte and mineral disturbance associated with TPN in preterm receiving it
NA, K, MG, P, CA.
14 days
Secondary Outcomes (1)
prevalence of cholestasis and sepsis in preterm receiving TPN
14 days
Interventions
Total parenteral nutrition
Eligibility Criteria
This study will include all male and female preterm infants receiving total parenteral nutrition in NICU of Cairo university Children hospital
You may qualify if:
- \- All preterm infants with gestational age \< 34 weeks, Receiving total parenteral nutrition. Normal serum magnesium.
You may not qualify if:
- Any full-term neonates Any patient with TORCH infection, chromosomal, metabolic disorders or surgical abnormality of the hepatobiliary system
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
Faculty of Medicine
Cairo, Almanyal, 11562, Egypt
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- doctor
Study Record Dates
First Submitted
January 21, 2021
First Posted
January 26, 2021
Study Start
April 7, 2019
Primary Completion
March 7, 2020
Study Completion
December 7, 2021
Last Updated
January 26, 2021
Record last verified: 2021-01